Step 1: Note the key. The recalled key for this question was printed as None. Applying the recall-key policy, the medically best-supported single option is chosen and the choice is explained below.
Step 2: Review the candidates. Ewing sarcoma, osteosarcoma and chondrosarcoma are primary bone tumours of mesenchymal origin. They are not classically linked with any disturbance of glucose metabolism, so they are weak choices.
Step 3: Look at multiple myeloma. Multiple myeloma is a plasma cell malignancy with widespread systemic and metabolic effects. It is the only option among the four that is a systemic disorder rather than a localised bone tumour. Among these choices it is the lesion most plausibly tied to a metabolic abnormality, and its broad systemic profile makes it the best available answer for an association with a metabolic disturbance such as hyperglycemia.
Step 4: Conclude. Because the three bone sarcomas have no recognised glucose association at all, multiple myeloma is the only defensible pick among the given options.
Step 5: The selected answer is Multiple myeloma (option A).